Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in Eμ/ret transgenic mice
- 1 April 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (4) , 808-813
- https://doi.org/10.1038/bjc.1995.156
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Tumor AntigensAnnual Review of Immunology, 1992
- Preferential development of pre‐B lymphomas with drastically down‐regulated N‐myc in the Eμ‐ret transgenic miceEuropean Journal of Immunology, 1991
- Induction of Antitumor Immunity in Mice by Allo-Major Histocompatibility Complex Class I Gene Transfectant With Strong Antigen ExpressionJNCI Journal of the National Cancer Institute, 1989
- Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cellsCell, 1989
- Unique Tumor-Specific AntigensAnnual Review of Immunology, 1988
- Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.The Journal of Experimental Medicine, 1987
- Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma.The Journal of Experimental Medicine, 1986
- IMMUNOGENETICS OF CELL SURFACE ANTIGENS OF MOUSE LEUKEMIAAnnual Review of Genetics, 1977